THERAPY OF ACUTE, CHRONIC AND MIXED HEPATIC PORPHYRIA PATIENTS WITH CHELATING AGENTS

被引：38

作者：

PETERS, HA

EICHMAN, PL

REESE, HH

机构：

来源：

关键词：

D O I：

10.1212/WNL.8.8.621

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：621 / 632

页数：12

共 36 条

[1] ALTERATION OF COPPER METABOLISM IN CHLORPROMAZINE-TREATED CASES
AZIMA, H
RICHMAN, A
[J]. ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1956, 75 (FEB): : 163 - 166
[2] CHELATION
BESSMAN, SP
DOORENBOS, NJ
[J]. ANNALS OF INTERNAL MEDICINE, 1957, 47 (05) : 1036 - 1041
[3] BLANSHARD TP, 1953, P SOC EXP BIOL MED, V82, P512
[4] CHENOWETH MB, 1956, PHARMACOL REV, V8, P57
[5] PORPHYRIA
DEAN, G
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1953, 2 (4849): : 1291 - 1294
[6] DEAN G, 1958, BRIT MJ, V5066, P298
[7] Derrien E, 1930, CR SOC BIOL, V103, P126
[8] DERRIEN E, 1928, B SOC CHIM FR, V43, P522
[9] EALES L, COMMUNICATION
[10] GIBSON KD, 1954, BIOCHEM J, V58, pR41